Stephen A Bremner

Featured in: Favicon

wiley.com (+1) Favicon

tandfonline.com Favicon

medscape.com Favicon

thelancet.com Favicon

jacionline.org Favicon

dailybusinessgroup.co.uk Favicon

plos.org + 2 more

Articles

Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease

Jul 14, 2023 | journals.plos.org | Daniel Bradshaw |Stephen A Bremner |Sumita Verma |Iga Abramowicz

AnalysesSample size. This was a pilot study evaluating feasibility, with the intention that results would be used to estimate the variability of the treatment effect of MVC on the ELF score. This in turn would inform the sample size calculation for an RCT to evaluate drug efficacy. We based our sample size justification for this pilot study on change in ELF score.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →